ZevAryehWainbergMD
Oncology • Santa Monica, CAHematologic Oncology
Assistant Professor, Medicine, UCLA School of Medicine
Dr. Wainberg is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2020 Santa Monica Blvd
Santa Monica, CA 90404Phone(310) 829-5471
Fax(310) 829-6192- Is this information wrong?
Education & Training
UCLA Medical CenterFellowship, Hematology/Oncology, 2003 - 2006
Albert Einstein College of MedicineResidency, Internal Medicine, 2000 - 2003
Tel Aviv University SacklerClass of 2000
Certifications & Licensure
CA State Medical License 2003 - 2023- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Start of enrollment: 2015 Dec 01Fu S.,Goff L.,Hwang J.,Kelly R.,Lockhart A.,Safran H.,Wainberg Z.
- PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2014 Jun 01Wainberg, Z.
- A Phase Ib/II, Open-label, Multi-center, Dose Escalation Study of MEK162 in Combination With Panitumumab in Adult Patients With Mutant RAS or Wild-type RAS Metastatic Colorectal Cancer Start of enrollment: 2013 Nov 01Saltz, L.,Wainberg, Z.A.
- Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors Start of enrollment: 2013 Aug 01Britten, C.,Hoff, D.V.,Karlin, D.,Wainberg, Z.
- Safety and Tolerability Study in Solid Tumors Start of enrollment: 2013 Mar 01Avila, A.,Starodub, A.,Parks, B.,Gordon, B.,Thai, D.,Courtney, G.,Sacks, H.,Coughran, J.,Martin, J.,Bendell, J.,Berlin, J.,Chaves, J.,Windsor, K.,Will, K.,Yonemoto, L.,Patel, M.,Shah, M.,Gordon, M.,Patel,...
- A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors Start of enrollment: 2012 Nov 01Infante, J.R.,Schwartz, G.K.,Wainberg, Z.A.
- A Phase lb/II Multi-center, Open-label, Dose Escalation Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in Patients With BRAF Mutant Metastatic Colorectal Cancer Start of enrollment: 2012 Nov 01Saltz, L.,Gutierrez, M.E.,Hochster, H.S.,Faris, J.E.,Wainberg, Z.A.,Sharma, S.,Berlin, J.,Bendell, J.,Bekaii-Saab, T.S.
- Join now to see all
Publications & Presentations
PubMed
- Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.Gelderblom, H., Wagner, A. J., Tap, W. D., Palmerini, E., Wainberg, Z. A., Desai, J., Healey, J. H., van de Sande, M. A., Bernthal, N. M., Staals, E. L., Peterfy, C. G...> ;Cancer. 2020 Nov 17
- Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer – Authors' replyVivek Subbiah, Ulrik Lassen, Eduard Gasal, Paul Burgess, Zev A. Wainberg> ;Lancet Oncology. 2020 Nov 1
- Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.Johanna C. Bendell, Sunil Sharma, Manish R. Patel, Kevin S Windsor, Zev A. Wainberg, Michael Gordon, Jorge Chaves, Jordan Berlin, Carrie Baker Brachmann, Marianna Zavo...> ;Oncologist. 2020 Nov 1
- Join now to see all
Journal Articles
- Efficacy and Safety of Pembrolizumab or Pembrolizumab plus Chemotherapy vs Chemotherapy Alone for Patients with First-Line, Advanced Gastric CancerAl Benson, Zev A Wainberg, JAMA Oncology
Lectures
- First-line durvalumab + monalizumab, mFOLFOX6, and bevacizumab or cetuximab for metastatic microsatellite-stable colorectal cancer (MSS-CRC).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Efficacy of pembrolizumab (pembro) monotherapy versus chemotherapy for PD-L1–positive (CPS ≥10) advanced G/GEJ cancer in the phase II KEYNOTE-059 (cohort 1) and phase ...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) can...2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Press Mentions
Dr. Wainberg on Impact of PD-L1 Status in Gastric/GEJ Cancer TreatmentJanuary 25th, 2020
Ipsen and Servier Announce Initial Phase 1/2 Clinical Data Evaluating Liposomal Irinotecan (ONIVYDE®) as an Investigational First-Line Treatment for Metastatic Pancreatic Cancer at ESMO 21st World Congress on Gastrointestinal CancerJuly 5th, 2019
Patients with Rare Digestive Tract Cancers Respond to New Drug CombinationNovember 19th, 2018- Join now to see all
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California
UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
